Wellington Zhaotai Therapies Limited is a joint venture company between Hunan Zhaotai Medical Group (Changsha, China) and the Malaghan Institute of Medical Research (Wellington, New Zealand).

​

Established in 2017 to take Hunan Zhaotai's novel CAR T-cell technology to the global market, the joint venture brings together the best of CAR T-cell research and development in China and New Zealand.

​